Abstract
Purpose
To evaluate liver function improvement and volume gain after percutaneous recanalization of chronic portal vein thrombosis (PVT) in non-cirrhotic patients.
Materials and Methods
In this retrospective study, five non-cirrhotic participants between 21 and 67 years old with secondary chronic PVT (4–21 years from diagnose) were submitted to percutaneous portal vein recanalization, followed by varices and shunts embolization.
Results
After a mean of 12.6 months, all portal veins remained patent and there was complete resolution of portal hypertension (PH) symptoms in all participants. There was a significant increase in liver volume of 39.8 ± 19.0% (p = 0.042), platelets count of 53120 ± 20188/μl (p = 0.042), and a significant decrease in total bilirubin levels from 1.04 ± 0.23 mg/dL to 0.51 ± 0.09 mg/dL (p = 0.043). We also found a non-significant increase in albumin levels from 3.88 ± 0.39 g/dL to 4.38 ± 0.27 g/dL (p = 0.078) and decrease in spleen diameter from 16.88 ± 4.03 cm to 14.15 ± 2.72 cm (p = 0.068).
Discussion
In this retrospective study, even with a small number of participants, we were capable of showing a median of 39.8% increase in liver volume, laboratorial liver function improvement, platelets count and resolution of PH symptoms, including gastroesophageal varices disappearance after portal vein recanalization followed by shunt embolization.
Conclusion
In this small series of cases, recanalization of chronic PVT in non-cirrhotic participants was feasible, successful and safe despite the prolonged time of occlusion. This is a new and promising approaching to an old and still challenging disease.
Abbreviations
- CT:
-
Computed tomography
- GI:
-
Gastrointestinal
- HE:
-
Hepatic encephalopathy
- INR:
-
International normalized ratio
- MELD:
-
Model for end-stage liver disease
- PVT:
-
Portal vein thrombosis
- PH:
-
Portal hypertension
- TIPS:
-
Transjugular intrahepatic portosystemic shunt
References
Sharma AM, Zhu D, Henry Z. Portal vein thrombosis: When to treat and how? Vasc Med. 2016;21(1):61–9.
DeLeve LD, Valla DC, Garcia-Tsao G. Vascular disorders of the liver. AASLD practice guidelines. Hepatology. 2009;49:1729–64.
Harris M, Thachil J. Portal vein thrombosis – a primer for the general physician. Clin Med. 2017;17(3):212–9.
Loffredo L, Pastori D, Farcomeni A, Violi F. Effects of anticoagulants in participants with cirrhosis and portal vein thrombosis: a systematic review and meta-analysis. Gastroenterology. 2017;53(2):480–7.
Nicoletti V, Gioia S, Lucatelli P, et al. Hepatic encephalopathy in patients with non-cirrhotic portal hypertension: description, prevalence and risk factors. Dig Liver Dis. 2016;48(9):1072–7.
Gioia S, Nardelli S, Ridola L, Riggio O. Causes and management of non-cirrhotic portal hypertension. Curr Gastroenterol Rep. 2020;22(12):56.
Intagliata NM, Caldwell SH, Tripodi A. Diagnosis, development, and treatment of portal vein thrombosis in participants with and without cirrhosis. Gastroenterology. 2019;156(6):1582–99.
de Franchis R, Faculty BVI. Expanding consensus in portal hypertension: report of the Baveno VI consensus workshop: stratifying risk and individualizing care for portal hypertension. J Hepatol. 2015;63(3):743–52.
Fanelli F, Angeloni S, Salvatori, et al. Transjugular intrahepatic portosystemic shunt with expanded-polytetrafuoroethylene-covered stents in non-cirrhotic patients with portal cavernoma. Digestive Liver Disease. 2011;43(1):78–84.
Wu M, Schuster M, Tadros M. Update on management of portal vein thrombosis and the role of novel anticoagulants. J Clin Transl Hepatol. 2019;7:1–11.
Funding
This study was not supported by any funding.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Human and Animal Rights
All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
Informed Consent
Informed consent was obtained from all individual participants included in the study.
Consent for Publication
For this type of study consent for publication is not required.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Levigard, R.B., Salas, H., Serrão, H. et al. Liver Growth and Portal Hypertension Improvement After Percutaneous Recanalization of Chronic Portal Vein Thrombosis in Non-Cirrhotic Participants. Cardiovasc Intervent Radiol 45, 582–589 (2022). https://doi.org/10.1007/s00270-022-03065-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00270-022-03065-7